JUMP TO CONTENT

What are the four phases of a clinical trial?

Posting date: 22/05/2022
Author: Inside ICON

Having enjoyed steady growth over the last several years, it’s predicted that the global clinical trials market will hit a value of $65.2 billion by 2025, and around 58% of this can be attributed to research within oncology. This is being driven by an increased demand for Clinical Research Organisations (CROs) to conduct clinical trials, a move towards personalised treatment and digitalisation of the healthcare market.

Despite the notable expansion of the market, it can take up to 15 years to get a new medicine or treatment to market because of the lengthy procedure of obtaining a licence. The process is split into distinct stages and each is thought of as a separate study where researchers are only permitted to move to the next stage once the U.S. Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA), European Medicines Agency (EMA) or other regulatory agency gives their approval. Here are the four phases of a clinical trial.

Phase I

Though there is sometimes a phase 0 to test whether researchers were correct about the way the body reacts to a drug, often clinical trials will start at phase I. A clinical trial refers to a study within clinical research where patients are monitored to determine the efficacy of a treatment; this can be a drug, medical device or procedure. Therefore, from the very first stage, a clinical operations team will be testing to see how the drug is broken down by the body, looking for side effects and beginning to find the optimal dosage.

Phase I ranges between several months to a year and tests the treatment on a small group of healthy patients. Once the trial is complete the drug safety associate (DSA) will submit their research to the regulatory agency at which point the FDA reports that around 7 in 10 receive approval.

Phase II

Those drugs, wearables or other treatments that pass approval at the first stage of clinical trials will progress to phase II where the focus is to test on a larger sample and typically introduce a placebo group. The placebo group - usually a randomised sample - will receive an inactive drug or a dummy treatment which allows clinical research associates (CRAs) to identify whether patients show side effects because they believe they’re receiving the treatment. Researchers can then compare the effectiveness of the treatment against the placebo group to get a clear picture of how well it works.

At this stage, clinical trial assistants (CTAs) are also assessing the safety of the treatment and monitoring any short-term adverse effects and phase II will normally span two years. The FDA reveals that the success rate at this stage is just 33%.

Phase III

At phase III, a clinical trial manager will work alongside the project manager to identify if the drug has an overall positive effect on the patient’s wellbeing. Having qualified to this stage CRO companies will recruit more patients into randomised groups to get a clearer picture of data discrepancies and therefore understand the success of the drug.

Treatments which receive approval after phase III are awarded a licence meaning that the medicine can go to market and be prescribed to the public. Over the last 10 years, US drug manufacturers have spent on average $1 billion getting their drug to market and this is partially due to rising costs associated with advancements in technology.

Read more on why you should be a project manager.

HTML Image as link


Phase IV

The fourth and final stage is tested once the drug has gone to market and is designed to understand the side effects better and establish if there are any long-term risks throughout the life span of the drug. At phase IV DSAs are evaluating the outcomes on a more wide-spread basis – generally in the thousands.

Work on some of the most exciting clinical trials with ICON

At ICON, we’re determined to be the partner of choice in drug development and this ambition sees us working on an extensive variety of projects. For more insight read about the impact of Covid-19 on pharmacovigilance.

Related Content

List #1

Related jobs at ICON

Trial Vendor Associate Director

Salary

Location

United Kingdom, Europe

Department

Clinical Trial Management

Location

Any EMEA Location

UK

Remote Working

Home-Based

Area of interest

Europe ICON Full Service & Corporate Support Talent Acquisition

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Assoicate Director of Vendor Management you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.

Reference

2025-122011

Expiry date

01/01/0001

Rajvir Samra

Author

Rajvir Samra
Read more Shortlist Save this role
Clinical Trial Manager

Salary

Location

Poland

Department

Clinical Trial Management

Location

Poland

Remote Working

Home-Based

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Clinical Trial Manager, you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence

Reference

2025-122115

Expiry date

01/01/0001

Dagmara Drozdowska Read more Shortlist Save this role
CTA

Salary

Location

India, Chennai

Location

Chennai

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

Clinical Trial Support

Job Type

Permanent

Description

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotech

Reference

JR134370

Expiry date

01/01/0001

Nandhini Selvakumar Read more Shortlist Save this role
Clinical Research Lead

Salary

Location

Netherlands

Department

Clinical Trial Management

Location

Netherlands

Remote Working

Home-Based

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

We are hiring a Clinical Research Lead, sponsor dedicated in Brussels, Belgium.Our client is a medicine company turning science into healing to make life better for people around the world. Would you

Reference

2025-121826

Expiry date

01/01/0001

Vanessa Verdickt Read more Shortlist Save this role
View all
List #1

Related stories

female pharmacist selecting medicine
Careers in Pharmacovigilance: Opportunities in Patient Safety and Drug Development

Teaser label

Industry

Content type

Blogs

Publish date

08/25/2025

Summary

Careers in Pharmacovigilance Pharmacovigilance, also known as drug safety, is one of the most important pillars of modern medicine. It ensures that once a medicine is developed, tested, and appro

Teaser label

Learn the skills that open doors to a career in drug safety and development.

Read more
Headshot of female
Leadership in Mexico: Karen Hahn’s Journey at ICON

Teaser label

Our People

Content type

Blogs

Publish date

08/14/2025

Summary

A Leader’s Journey: Karen Hahn on Growth, Culture and the Future of ICON Mexico Karen Hahn’s career at ICON has unfolded over more than 15 years, shaped not by a rigid plan, but by openness to ch

Teaser label

Over 15 years, Karen Hahn has grown alongside ICON Mexico - from a team of 40 in 2010 to over 2,000 today.

Read more
Headshot of female
Building a Career at ICON: Susie's journey from HR Analyst to Senior VP

Teaser label

Inside ICON

Content type

Blogs

Publish date

08/07/2025

Summary

Building a Career at ICON: A Conversation with Susie McEvoy, Senior VP of HR At ICON, career journeys are rarely linear – and Susie McEvoy’s story is a powerful example of that. From joining as a

Teaser label

Discover how Susie built a successful career at ICON, progressing from HR Analyst to Senior Vice President.

Read more
View all
List #1

Recently viewed jobs

View Jobs

Browse popular job categories below or search all jobs above